网站主页 >> CAS数据库列表 >> 3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
|
|
- CAS号:
- 908601-15-0
- 英文名:
- FMOC-TRP(BOC)-SER(PSIME,MEPRO)-OH
- 英文别名:
- Fmoc-Trp(Boc)-Ser(ψMe,Me Pro)-OH;FMOC-TRP(BOC)-SER(PSIME,MEPRO)-OH;FMOC-TRP(BOC)-SER(PSIME,MEPRO)-OH_ 908601-15-0;(9H-Fluoren-9-yl)MethOxy]Carbonyl Trp(Boc)-SerPsi(Me, Me)Pro-OH;(S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoyl)-2,2-dimethyloxazolidine-5-carboxylic acid;(4S)-3-[(2S)-3-{1-[(tert-butoxy)carbonyl]-1H-indol-3-yl}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;3-[(2S)-3-[(5S)-5-Carboxy-2,2-dimethyl-3-oxazolidinyl]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-oxopropyl]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester;1H-Indole-1-carboxylic acid, 3-[(2S)-3-[(5S)-5-carboxy-2,2-dimethyl-3-oxazolidinyl]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-oxopropyl]-, 1-(1,1-dimethylethyl) ester
- 中文名:
- 3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
- 中文别名:
- 3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯;(S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(1-(叔丁氧基羰基)-1H-吲哚-3-基)丙酰基)-2,2-二甲基恶唑烷-5-羧酸
- CBNumber:
- CB3209345
- 分子式:
- C37H39N3O8
- 分子量:
- 653.72
- MOL File:
- 908601-15-0.mol
|
|
|
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯化学性质
-
密度:
-
1.32±0.1 g/cm3(Predicted)
-
|
-
酸度系数(pKa):
-
3.12±0.40(Predicted)
-
|
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯性质、用途与生产工艺
Fmoc-Tyr(tBu)-Ser(psi(Me,Me)pro)-OH 是一种二肽。
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
上下游产品信息
上游原料
下游产品
3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
生产厂家
908601-15-0, 3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯 相关搜索:
丝半胱氨酸伪二肽 (4S)-3-[(2S)-6-[[叔丁氧羰基]氨基]-2-[[芴甲氧羰基]氨基]-1-氧代己基]-2,2-二甲基-4-恶唑烷羧酸 (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S,5R)-3-[(2S)-6-[[叔丁氧羰基]氨基]-2-[[芴甲氧羰基]氨基]-1-氧代己基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1-氧代-3-苯基丙基]-2,2-二甲基-4-恶唑烷羧酸 (4S,5R)-3-[(2S,3R)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丁基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸 D-丝氨酸伪二肽 (4S,5R)-3-[(2S)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸 (5R)-3-[(2S)-3-[1-[叔丁氧羰基]-1H-吲哚-3-基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 (4S)-3-[(2S,3R)-3-(叔丁氧基)-2-[[芴甲氧羰基]氨基]-1-氧代丁基]-2,2-二甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代丁基]-2,2,5-三甲基-4-恶唑烷羧酸
- peptide
- 假二肽
- C37H39N3O8
- (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(1-(叔丁氧基羰基)-1H-吲哚-3-基)丙酰基)-2,2-二甲基恶唑烷-5-羧酸
- 3-[(2S)-3-[(5S)-5-羧基-2,2-二甲基-3-恶唑烷基]-2-[[芴甲氧羰基]氨基]-3-氧代丙基]-1H-吲哚-1-羧酸叔丁酯
- 908601-15-0
- (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoyl)-2,2-dimethyloxazolidine-5-carboxylic acid
- 1H-Indole-1-carboxylic acid, 3-[(2S)-3-[(5S)-5-carboxy-2,2-dimethyl-3-oxazolidinyl]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-oxopropyl]-, 1-(1,1-dimethylethyl) ester
- Fmoc-Trp(Boc)-Ser(ψMe,Me Pro)-OH
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Trp(Boc)-SerPsi(Me, Me)Pro-OH
- FMOC-TRP(BOC)-SER(PSIME,MEPRO)-OH_ 908601-15-0
- (4S)-3-[(2S)-3-{1-[(tert-butoxy)carbonyl]-1H-indol-3-yl}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
- 3-[(2S)-3-[(5S)-5-Carboxy-2,2-dimethyl-3-oxazolidinyl]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-oxopropyl]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester
- FMOC-TRP(BOC)-SER(PSIME,MEPRO)-OH